Evidence map›Paper›PMID 36673037›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Protocol of Breast Cancer Prevention Model with Addition of Breast Ultrasound to Routine Gynecological Visits as a Chance for an Early Diagnosis and Treatment in 25 to 49-Year-Old Polish Females.

Marcin Śniadecki, Paulina Jaworek, Zuzanna Chmielewska, Patryk Poniewierza, Maria Stasiak, Martyna Danielkiewicz, Damian Stencelewski, Michał Brzeziński, Zuzanna Anna Boyke, Ewa Wycinka and 10 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 2 countries.

Marcin ŚniadeckiDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.ORCID 0000-0002-9587-0476
Paulina JaworekDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Zuzanna ChmielewskaDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.ORCID 0000-0003-1106-1119
Patryk PoniewierzaMedicover, Al. Jerozolimskie 96, 00-807 Warszawa, Poland.
Maria StasiakDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Martyna DanielkiewiczDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Damian StencelewskiDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Michał BrzezińskiDepartment of Gynecological Oncology, PCK Marine Hospital in Gdynia, 81-519 Gdynia, Poland.ORCID 0000-0001-6733-3465
Zuzanna Anna BoykeDepartment of Art History, Faculty of History, University of Gdansk, 80-309 Gdańsk, Poland.
Ewa WycinkaDepartment of Statistics, Faculty of Management, University of Gdansk, 81-824 Sopot, Poland.
Medha SunilDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Marie NguyenDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Dagmara Klasa-MazurkiewiczDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.ORCID 0000-0003-0122-9504
Krzysztof KoziełekMammography Laboratory, HCP Medical Center, Hospital St. John Paul II, 61-001 Poznan, Poland.
Piotr RakWyspa Medycyny Przyjaznej [The Island of Friendly Medicine], 80-747 Gdańsk, Poland.
Yvonne WolnyAmita Health St. Joseph Hospital Chicago, Chicago, IL 60657, USA.
Marcin LiroDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Paweł Władysław GuzikClinical Department of Gynecology and Obstetrics, City Hospital, 35-241 Rzeszów, Poland.
Katarzyna Dobruch-SobczakUltrasound Department, Institute of Fundamental Technological Research, Polish Academy of Sciences, 02-106 Warsaw, Poland.ORCID 0000-0003-1470-4140
Dariusz WydraDepartment of Gynecology and Obstetrics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Gdańsk Medical University · PLUniversity of Gdańsk · PLAmerican Health Information Management Association · USGdynia Maritime University · PLInstitute of Fundamental Technological Research · PLJohn Paul II Hospital · PLMeditest · PLTrinity Hospital of Augusta · USUczelnia Łazarskiego · PLUniversity of Rzeszów · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The low attendance rate for cancer screening tests in Poland is a major healthcare concern that requires specific analysis and the development of implementation recommendations for prevention, and both actions are likely to benefit culturally similar countries. Four female cancers account for approximately 20% of all cancer cases-breast cancer, cervical cancer, endometrial cancer, and ovarian cancer-suggesting that gynecologists have a significant preventative role. Of the four, breast cancer and cervical cancer are among the 10 most common malignant neoplasms globally, regardless of gender, occur only in women and are known to have effective screening measures. Our research aims to create a screening model that combines cervical cancer and breast cancer to maximize health outcomes for women at risk of both cancers. In the study protocol, we have created a model that maximizes benefits for patients with minimal additional costs to the health care system. To achieve the set goal, instead of regular clinical breast exams as recommended by the gynecological societies, we proposed an ultrasound examination, during which palpation may also be performed (in the absence of elastography). We present a scheme for such a protocol that takes into consideration all types of prevention in both cancers, and that emphasizes breast ultrasound as the most frequently missing element. Our study includes a discussion of the strengths and weaknesses of our strategy, and the crucial need for infrastructure and education for the successful implementation of the program. We conclude that our model merits consideration and discussion among health-care decision makers, as the screening changes we propose have significant potential benefits for the female population.

Indexed as

breast cancercervical cancerhealth policymammographyscreeningsenologyultrasonographyvalue-based healthcare

Identifiers

PMID36673037
PMCPMC9857976
OpenAlexW4313826506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.